Researchers discover how PARP inhibitors selectively kill BRCA-mutant cancer cells
 

A team of Massachusetts General Hospital researchers has discovered how an important class of anti-cancer drugs called PARP inhibitors works, a finding that could help improve treatment and prolong survival for patients with breast cancer and other malignancies.

More...